Imunon Management
Management criteria checks 3/4
Imunon's CEO is Stacy Lindborg, appointed in May 2024, has a tenure of less than a year. directly owns 1.82% of the company’s shares, worth €207.09K. The average tenure of the management team and the board of directors is 0.6 years and 6.4 years respectively.
Key information
Stacy Lindborg
Chief executive officer
US$44.1k
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 1.8% |
Management average tenure | less than a year |
Board average tenure | 6.4yrs |
Recent management updates
Recent updates
CEO
Stacy Lindborg (54 yo)
less than a year
Tenure
US$44,095
Compensation
Dr. Stacy R. Lindborg, Ph D., was Co-Chief Executive Officer of Brainstorm Cell Therapeutics Inc. since January 2023 until May 09, 2024 and serves as its Director since May 09, 2024. Dr. Lindborg joined th...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 17.9yrs | no data | 2.44% € 277.0k | |
President | less than a year | US$44.10k | 1.82% € 207.1k | |
Executive VP & Chief Scientific Officer | 10.5yrs | US$680.16k | 0.020% € 2.2k | |
CFO & Corporate Secretary | less than a year | no data | no data | |
Chief Accounting Officer & Controller | 14.9yrs | US$137.75k | no data | |
General Counsel & Corporate Secretary | less than a year | no data | no data | |
Senior Vice President of Strategic Operations | less than a year | no data | no data |
0.6yrs
Average Tenure
64yo
Average Age
Experienced Management: CBO's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 17.9yrs | no data | 2.44% € 277.0k | |
President | 3.5yrs | US$44.10k | 1.82% € 207.1k | |
Independent Director | 9yrs | US$72.90k | 0.0041% € 468.4 | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Independent Director | 2.3yrs | US$61.20k | 0% € 0 | |
Independent Director | 13.4yrs | US$106.20k | 0.081% € 9.2k | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of Advisory Board | no data | no data | no data | |
Member of the Advisory Board | 3.8yrs | no data | no data |
6.4yrs
Average Tenure
73yo
Average Age
Experienced Board: CBO's board of directors are considered experienced (6.4 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 13:55 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Imunon, Inc. is covered by 17 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
James Molloy | Alliance Global Partners |
Raymond Deacon | Brean Capital |
Kumaraguru Raja | Brookline Capital Markets |